Tag: Europe
-
Nerve-Blocking Treatment for Diabetes Approved in Europe
29 September 2014. EnteroMedics Inc., a medical device developer in St. Paul, Minnesota, says marketing approval in Europe for its vagus nerve blocking device for obesity is extended to cover type 2 diabetes. A CE Mark, which signifies approval to market regulated products such as medical devices in the European Union and associated countries, is…
-
Boehringer Ingelheim Licenses RNA Lung Cancer Immunotherapy
19 September 2014. The pharmaceutical company Boehringer Ingelheim is licensing from biopharmaceutical enterprise CureVac a vaccine based on RNA to generate an immune response for treating lung cancer. The deal has a total potential value to CureVac of €465 million ($US 597 million). CureVac, in Tübingen, Germany, develops vaccines and treatments based on messenger RNA,…
-
Sanofi, MyoKardia Partner on Genetic Heart Disorders
17 September 2014. The pharmaceutical company Sanofi and biopharmaceutical developer MyoKardia are collaborating on development and commercialization of three MyoKardia therapies for inherited heart diseases. The deal could earn MyoKardia as much as $200 million in milestone payments and equity investments from Sanofi. MyoKardia, in South San Francisco, California, designs small-molecule therapies for two types…
-
Lilly, AstraZeneca Collaborate on Alzheimer’s Drug
16 September 2014. The pharmaceutical companies Eli Lilly and Company and AstraZeneca will jointly develop a drug to treat Alzheimer’s disease, currently in early-stage clinical trials. In the $500 million deal, Lilly is licensing research and development conducted so far by AstraZeneca, with the companies dividing up further clinical development, commercialization, and manufacturing of the…
-
Coffee Genome Sequenced, Caffeine Enzymes Analyzed
5 September 2014. An international team of researchers sequenced the genome of a major type of coffee that revealed the evolutionary pathway of this popular drink, and more details about caffeine, a main attraction of coffee. The team was led by Institute of Research for Development and National Sequencing Center, both in France, and University…
-
Multi-Purpose Drug Boosts Adherence After Heart Attack
3 September 2014. Researchers at Mount Sinai Hospital in New York and National Centre for Cardiovascular Research in Madrid, Spain found a pill combining three cardiovascular drugs usually prescribed separately helps heart attack patients stick to their medications better than the three drugs taken separately. The team led by Valentin Fuster, accredited to both institutions,…
-
Biotech, Universities to Test Hydrogel for Vocal Fold Scars
28 August 2014. BioTime Inc., a biotechnology company in Alameida, California, is partnering with researchers at University of Wisconsin and Université catholique de Louvain in Belgium to test its hydrogels for treating vocal cord scarring, a voice problem that results from injury or disease. Financial terms of the collaboration were not disclosed. Vocal folds are…
-
University Starts Computer Science/Brain Research Consortium
26 August 2014. Carnegie Mellon University in Pittsburgh organized an international consortium of researchers to apply computer science techniques to the study of brain research and behavior. The collaboration, known as BrainHub, includes researchers from nearby University of Pittsburgh, as well as Sun Yat-sen University in Guangzhou, China, Indian Institute of Science in Bangalore, and…
-
Genetically Engineered Medflies Found to Control Wild Types
13 August 2014. Researchers at the biotechnology company Oxitec Ltd. in Oxford and University of East Anglia in Norwich, both in the U.K., created a modified form of the Mediterranean fruit fly that tests show can reduce the population of this pest responsible for extensive crop damage in many parts of the world. Results of…
-
Trial Shows Stem Cell Treatment Feasibility for Stroke
8 August 2014. An early-stage clinical trial shows treating stroke patients with their own bone-marrow stem cells is safe and feasible, and provides evidence of improving cognitive and motor functions. The study conducted by Imperial College London and affiliated hospitals in the U.K. appears today in the journal Stem Cells Translational Medicine (registration required). The…